Day: December 10, 2019

NEW YORK, Dec. 10, 2019 (GLOBE NEWSWIRE) — iBio, Inc. (NYSE AMERICAN:IBIO) today unveiled the FastGlycaneering Development Service™, which includes an array of new glycosylation technologies for engineering high-performance recombinant proteins. Biopharmaceutical innovators and biosimilar producers will now be able to take advantage of low-cost afucosylation controls, oligomannose modification capabilities, and more custom glycosylation techniques using iBio’s plant-based manufacturing platform in order to rapidly develop high-quality biobetters, novel antibody therapeutics, and biosimilars.“Combining the potency delivered by advanced glycan engineering technologies with the speed of iBio’s FastPharming Manufacturing System™ creates a more efficient and effective alternative to producing biopharmaceuticals in CHO or other mammalian...

ELECTRICITE ET EAUX DE MADAGASCARC o m m u n i q u eÉtats Financiers Sociaux et ConsolidésExercice 2018Le Conseil d’Administration a arrêté les états financiers sociaux et consolidés dans sa séance du 9 décembre 2019.Chiffres Clés de l’ExerciceFaits marquants de l’exerciceCOMPTES SOCIAUXLes comptes sociaux se traduisent par une perte de (1.919) K euros, contre une perte de (2.706) K euros au titre de 2017.COMPTES CONSOLIDESLes comptes consolidés du groupe au titre de l’exercice clos le 31 décembre 2018 se traduisent par une perte consolidée de (1.405) K euros contre (6.704) K euros au titre de 2017.Le Groupe EEM enregistre au titre de l’exercice 2018, un chiffre d’affaires de 165 K euros. Le résultat opérationnel courant est de – 2,31 millions d’euros, en baisse par rapport à l’exercice 2017.Le résultat net est topujours fortement impacté...

SAN ANTONIO, Dec. 10, 2019 (GLOBE NEWSWIRE) — Valero Energy Corporation (NYSE: VLO, “Valero”) today announced that it will host a conference call on January 30, 2020, at 10:00 a.m. ET to discuss 2019 fourth quarter and full year earnings results, which will be released earlier that day, and provide an update on company operations.Persons interested in listening to the presentation live via the internet may log on to Valero’s web site at www.valero.com.About ValeroValero Energy Corporation, through its subsidiaries (collectively, “Valero”), is an international manufacturer and marketer of transportation fuels and petrochemical products. Valero is a Fortune 50 company based in San Antonio, Texas, and it operates 15 petroleum refineries with a combined throughput capacity of approximately 3.1 million barrels per day and 14 ethanol...

DALLAS, Dec. 10, 2019 (GLOBE NEWSWIRE) — A. H. Belo Corporation (NYSE: AHC) announced today that Jim Moroney, a director and former Chief Executive Officer of the Company, has sold a substantial portion of his holdings of A. H. Belo Series A and Series B Common Stock to Robert W. Decherd, the Company’s Chairman of the Board and Chief Executive Officer in several transactions.  These transactions include Series A and Series B holdings of the Jim and Lynn Moroney Family Foundation, Moroney Family Belo LLC, Moroney Venture Capital LP, and Moroney Preservation Limited, in addition to purchases from other Moroney family members.About A. H. Belo Corporation

PERTH, Western Australia, Dec. 11, 2019 (GLOBE NEWSWIRE) — Perseus Mining Limited (“Perseus” or the “Company”) (TSX & ASX: PRU) is pleased to advise that it has achieved another important milestone in the schedule for developing its third gold mine, the Yaouré Gold Mine in Côte d’Ivoire, with the award of a mining services contract to EPSA Internacional SA (“EPSA”).EPSA is a privately owned, global earthmoving and mining contractor that is headquartered in Spain and provides a range of mining, civil works and earthmoving services to a blue-chip list of mining clients located in 15 countries where they employ approximately 4,000 employees and deploy nearly 1,600 pieces of equipment.The mining services contract will run for a period of 65 months commencing on 1 November 2020 and envisages the movement of approximately 170 million...

SAN MATEO, Calif., Dec. 10, 2019 (GLOBE NEWSWIRE) — Franklin Resources, Inc. (the “Company”) [NYSE:BEN] announced a quarterly cash dividend in the amount of $0.27 per share payable on January 10, 2020 to stockholders of record holding shares of common stock at the close of business on December 31, 2019.  The quarterly dividend of $0.27 per share represents a 4% increase over the dividends paid for the prior quarter and the same quarter last year.  The Company has raised its dividend every year since 1981.  Franklin Resources, Inc. [NYSE:BEN] is a global investment management organization operating as Franklin Templeton. Franklin Templeton’s goal is to deliver better outcomes by providing global and domestic investment management to retail, institutional and sovereign wealth clients in over 170 countries. Through specialized teams,...

WARSAW, Ind., Dec. 10, 2019 (GLOBE NEWSWIRE) — OrthoPediatrics Corp. (“OrthoPediatrics”) (Nasdaq: KIDS), a company exclusively focused on advancing the field of pediatric orthopedics, announced today that it is commencing an underwritten public offering of its common stock. OrthoPediatrics and certain of its stockholders are proposing to sell shares of common stock, including shares to be offered by certain selling stockholders. OrthoPediatrics will not receive any proceeds from the sale of the shares by the selling stockholders. In addition, OrthoPediatrics intends to grant the underwriters a 30-day option to purchase additional shares of its common stock at the public offering price, less the underwriting discounts and commissions. The offering is subject to market and other conditions, and there can be no assurance as to whether...

TORONTO, Dec. 10, 2019 (GLOBE NEWSWIRE) — NorthWest Healthcare Properties Real Estate Investment Trust (“NorthWest” or the “REIT”) (TSX: NWH.UN) announced today a public offering, on a “bought deal” basis, of 16,400,000 trust units (the “Units”) at a price of $12.20 per Unit (the “Offering Price”) representing gross proceeds of approximately $200.1 million (the “Public Offering”). The Public Offering is being made through a syndicate of underwriters led by BMO Capital Markets, RBC Capital Markets, and Scotiabank.The REIT has also granted the underwriters the option to purchase up to an additional 2,460,000 Units to cover over-allotments, if any, exercisable in whole or in part anytime up to 30 days following closing of the Public Offering.Concurrently with the Public Offering, the REIT has also entered into...

RADNOR, Pa., Dec. 10, 2019 (GLOBE NEWSWIRE) — Marinus Pharmaceuticals, Inc. (NASDAQ: MRNS), (“Marinus” or the “Company”) today announced that it intends to offer and sell shares of its common stock in an underwritten public offering.  All of the shares in the offering are to be sold by Marinus.  Marinus also expects to grant the underwriters a 30-day option to purchase up to an additional 15 percent of the number of shares to be issued and sold in the public offering.  The offering is subject to market conditions, and there can be no assurance as to whether or when the offering may be completed, or as to the actual size or terms of the offering.Concurrently with the completion of the public offering, the Company expects to sell to certain investors in a private placement, a number of shares of convertible preferred stock equal to...